Express News | NYSE Order Imbalance 193787.0 Shares on Sell Side
Moomoo 24/7Apr 24 15:50 ET
Express News | NYSE Order Imbalance 50911.0 Shares on Buy Side
Moomoo 24/7Apr 22 15:50 ET
Improved Revenues Required Before Baxter International Inc. (NYSE:BAX) Shares Find Their Feet
You may think that with a price-to-sales (or "P/S") ratio of 1.4x Baxter International Inc. (NYSE:BAX) is a stock worth checking out, seeing as almost half of all the Medical Equipment companies in th
Simply Wall StApr 20 10:16 ET
Express News | NYSE Order Imbalance 89744.0 Shares on Sell Side
Moomoo 24/7Apr 17 15:50 ET
Non-Hodgkin Lymphoma Therapeutics Market Size Is Set to Grow by USD 5.42 Billion From 2023-2027, AstraZeneca Plc, Baxter International Inc. and Bayer AG, and More to Emerge as Some of the Key Vendors, Technavio
The global non-hodgkin lymphoma therapeutics market size is estimated to grow by USD 5427.51 mn from 2023 to 2027, according to Technavio. The market ...
PR NewswireApr 16 17:25 ET
Express News | NYSE Order Imbalance 65406.0 Shares on Sell Side
Moomoo 24/7Apr 16 15:50 ET
Express News | NYSE Order Imbalance 231500.0 Shares on Buy Side
Moomoo 24/7Apr 15 15:50 ET
Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio
Yahoo FinanceApr 12 11:00 ET
Comfort Systems USA and Boeing Have Been Highlighted as Zacks Bull and Bear of the Day
Yahoo FinanceApr 12 08:29 ET
Express News | Baxter International Inc: Continued Expansion of Its Pharmaceuticals Portfolio With Five Injectable Product Launches in U.S.
Moomoo 24/7Apr 11 08:32 ET
Express News | Baxter Expands Pharmaceuticals Portfolio With Five Injectable Products In U.S
Moomoo 24/7Apr 11 08:32 ET
Baxter Expands Pharmaceuticals Portfolio With New Injectable Products in the U.S.
Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.
BusinesswireApr 11 08:30 ET
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this
BusinesswireApr 10 16:15 ET
Reasons to Hold Baxter International (BAX) in Your Portfolio
Yahoo FinanceApr 10 11:58 ET
Baxter Is Deeply Undervalued
Yahoo FinanceApr 10 10:00 ET
Baxter to Host First-Quarter 2024 Conference Call for Investors Financial Results
Press Release DEERFIELD, Ill. - 2024-04-10 Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2
BaxterApr 10 00:00 ET
Shareholders in Baxter International (NYSE:BAX) Are in the Red If They Invested Three Years Ago
Yahoo FinanceApr 5 07:22 ET
Assessing Baxter Intl: Insights From 4 Financial Analysts
4 analysts have expressed a variety of opinions on Baxter Intl (NYSE:BAX) over the past quarter, offering a diverse set of opinions from bullish to bearish.The following table provides a quick overvie
BenzingaApr 3 12:00 ET
Baxter International Is Maintained at Neutral by Citigroup
Baxter International Is Maintained at Neutral by Citigroup
Dow JonesApr 3 11:43 ET
Express News | Citigroup Maintains Neutral on Baxter Intl, Raises Price Target to $44
Moomoo 24/7Apr 3 11:34 ET
No Data
No Data